Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Clinical trial NCT06172296 · RECRUITING
Trial details
- NCT number
- NCT06172296
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-19
- Primary completion
- 2029-12-31
- Enrollment
- 478
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.